Shares of Sensus Healthcare, Inc. (SRTS) have gained 1.1% over the past four weeks to close the last trading session at $6.44, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$10.67 indicates a potential upside of 65.7%.The average comprises three short-term price targets ranging from a low of $10 to a high of$12, with a standard deviation of $1.15. While the lowest estimate in ...